Sebastien Wälchli invited speaker at the 25th Porto Cancer Meeting
We will be at AACR 2018
Pierre Dillard will attend the 2018 meeting of the American Association for Cncer Research (AACR). He will present our recent work on universal killer, make sure to have a look !
New publication from our group in Cancer Immunology
Human c-SRC kinase (CSK) overexpression makes T cells dummy
Patient safety upon immunotherapy treatment is a challenge that still need to be adressed.
In this publication we report how by affecting c-SRC kinase we can make T-cells "dummy": effector cells are still able to recognize and bind to the target but unable to carry on with their activation. This mechanism could potentially open the way for a safe-lock system permitting to reduce off-target toxicity.
Image from: Ellen Tenstad/Science Shaped
T lymphocytes killing melanoma cells....
Nadia Mensali won the presentation prize at the annual NSI meeting!
Nadia Mensali was awarded with the presentation prize for her talk on the Universal Killer! See below to learn more
We will be at SITC 2017 !
Nadia Mensali and Pierre Dillard will attend the 2017 meeting of the Society for ImmunoTherapy of Cancer (SITC). They will present our recent work on universal killer and CD4 Adoptive cell therapy, make sure to have a look !
We published a new paper in Scientific Reports !
Our team published a new paper about using TCR in CAR design, make sure to have a look here !
Our research team is well represented in the new Olo Cancer Cluster presentation book!
The new Oslo Cancer Cluster presentation book is out!
Have a look here:
We will be at PIVAC 2017 at the end of September
Marit Renee Myhre has been selected to give a talk at the 17th International Conference on Progress in Vaccination Against Cancer (PIVAC 2017) in Loutraki, Corinth, Greece
She will present our latest work on our new CD4-based therapy, make sure to have a look at the abstract if you want to learn more !